05. Breast cancer (metastatic)
Metastatic breast cancer (also called stage IV) is breast cancer that has spread to another part of the body, most commonly to the liver, brain, bones, or lungs.
Cancer cells can break away from the original tumor in the breast and travel to other parts of the body through the bloodstream or the lymphatic system, which is a large network of nodes and vessels that works to remove bacteria, viruses, and cellular waste products.
Breast cancer relapses can occur in other sites, months or years after the original diagnosis and treatment. Nearly 30% of women diagnosed with early-stage breast cancer will develop a metastatic disease.
Some people have metastatic breast cancer at a first diagnosis, meaning that the cancer in the breast wasn’t detected before it spread to other parts of the body. This is what we call a “de novo” metastatic breast cancer.
While metastatic breast cancer may not disappear , treatment may help to control the disease for a number of years. The cancer can be active sometimes and then go into remission at other times. If one treatment stops working, there are usually a few other options – alone, in combination, or in sequence, that can be given to the patient. This module will provide you a comprehensive update on the role of metronomic chemotherapy in advanced breast cancer, detailing the data coming from studies which have used metronomic single agents, combination treatments with a focus on special populations of patients, such as frail or elderly ones.
- Lectures 17
- Quizzes 1
- Duration 1 hour
- Skill level All levels
- Language English
- Students 0
- Assessments Yes
Lesson 1 Pedro Sanchez-Rovida
Metronomic chemotherapy as single agent treatment
Lesson 2 Marina Elena Cazzaniga
Metronomic chemotherapy in combination regimens
Lesson 3 Edgar Petru
Side effects, from bench to bedside
Lesson 4 Elisabetta Munzone
Cross view in special populations
The quiz is mandatory only for those willing to achieve European CME credits. Please be aware that the ISMe® educational e-learning platform is in the process of being accredited by the European Accreditation Council for Continuing Medical Education (UEMS-EACCME)